← 홈

Antibody · 자가면역·염증성

168개 · ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-13 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 168개
AntibodystaleJanssenApproved

Trexan+Salazopyrin+Oxiklorin+prednisolone + infliximab (Trexan+Salazopyrin+Oxiklorin+prednisolone + infliximab)

Rheumatoid Arthritis · Rheumatoid Arthritis

#RheumatoidArthritis#Antibody#Approved#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleAbbViePreclinical

etanercept, infliximab, adalimumab, and golimumab (Tumor Necrosis Factor Inhibitor, Tumor Necrosis Factor Inhibitor (etanercept, infliximab, adalimumab, and golimumab))

Infection; Rheumatoid Arthritis · Infection

#Infection#Antibody#Preclinical#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleJanssenPreclinical

UST (Ustekinumab, Ustekinumab (UST))

Crohn's Disease · Crohn's Disease

#CrohnsDisease#Antibody#Preclinical#항체#면역항체+2
효능 ORR 3%임상시험 1상태 ACTIVE
AntibodystaleJanssenPreclinical

ustekinumab (Stelara, Ustekinumab - Standard Dosage)

Crohn Disease · Crohn Disease

#CrohnDisease#Antibody#Preclinical#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleJanssenPhase 3

mg (Ustekinumab 90 milligram, Ustekinumab 90 milligram (mg))

Lupus Erythematosus, Systemic · Lupus Erythematosus, Systemic

#LupusErythematosusSystemic#Antibody#Phase3#항체#면역항체+4
임상시험 1상태 DISCONTINUED
AntibodystaleAbbVieApproved

up to 9 months exposure (adalimumab, adalimumab (up to 9 months exposure))

Rheumatoid Arthritis · Rheumatoid Arthritis

#RheumatoidArthritis#Antibody#Approved#항체#면역항체+2
임상시험 1상태 DISCONTINUED
AntibodystaleAbbViePreclinical

adalimumab (Humira, adalimumab and methotrexate)

Psoriasi · Psoriasi

#Psoriasi#Antibody#Preclinical#항체#면역항체+2
효능 ORR 6.35%임상시험 1상태 ACTIVE
AntibodystaleAbbViePreclinical

ustekinumab (Stelara, adalimumab, infliximab, ustekinumab, golimumab, and vedolizumab)

Inflamatory Bowel Disease (Crohn's and Ulcerative Colitis) · Inflamatory Bowel Disease (Crohn's a

#InflamatoryBowelDiseaseCrohn39sa#Antibody#Preclinical#항체#면역항체+4
임상시험 1상태 RECRUITING
AntibodystaleAbbVieApproved

adalimumab (Humira, adalimumab, plus prednisone)

Rheumatoid Arthritis · Rheumatoid Arthritis

#RheumatoidArthritis#Antibody#Approved#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleAbbViePreclinical

adalimumab (Humira, adalimumab, secukinumab, ixekizumab, guselkumab, Jak inhibitors, methotrexate)

Immunoclassification; Psoriasis · Immunoclassification

#Immunoclassification#Antibody#Preclinical#항체#면역항체+3
임상시험 1상태 RECRUITING
AntibodystaleAbbViePhase 1

adalimumab (Humira, adalimumab-US source)

Healthy · Healthy

#Healthy#Antibody#Phase1#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleJanssenPhase 2

anti TNFa monoclonal antibody - Infliximab (anti TNFa monoclonal antibody - Infliximab)

Endometriosis · Endometriosis

#Endometriosis#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleImperial College LondonPreclinical

etanercept or adalimumab (anti-TNF therapy, anti-TNF therapy (etanercept or adalimumab))

Rheumatoid Arthritis; Ankylosing Spondylitis · Rheumatoid Arthritis

#RheumatoidArthritis#Antibody#Preclinical#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleAbbViePhase 3

adalimumab (Humira, azathioprine or adalimumab and infliximab)

Crohn Disease · Crohn Disease

#CrohnDisease#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleMedical University of GrazApproved

etanercept, adalimumab, infliximab, certolizumab, golimumab, tozilizumab, abatacept (bDMARD withdrawal, bDMARD withdrawal (etanercept, adalimumab, infliximab, certolizumab, golimumab, tozilizumab, abatacept))

Rheumatoid Arthritis · Rheumatoid Arthritis

#RheumatoidArthritis#Antibody#Approved#항체#면역항체+2
임상시험 1상태 DISCONTINUED
AntibodystaleJanssenApproved

daclizumab, infliximab (daclizumab, infliximab)

Graft vs Host Disease · Graft vs Host Disease

#GraftvsHostDisease#Antibody#Approved#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleUniversity of GlasgowApproved

adalimumab (Humira, etanercept or adalimumab)

Rheumatoid Arthritis · Rheumatoid Arthritis

#RheumatoidArthritis#Antibody#Approved#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleJanssenPreclinical

adalimumab (Humira, infliximab and adalimumab)

Crohn's Disease; Ulcerative Colitis · Crohn's Disease

#CrohnsDisease#Antibody#Preclinical#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleJanssenPreclinical

infliximab and azathioprine combination at week 0 (infliximab and azathioprine combination at week 0)

Crohn Disease · Crohn Disease

#CrohnDisease#Antibody#Preclinical#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleJanssenPreclinical

infliximab and azathioprine combination at week 14 (infliximab and azathioprine combination at week 14)

Crohn Disease · Crohn Disease

#CrohnDisease#Antibody#Preclinical#항체#면역항체+2
임상시험 1상태 ACTIVE

8 / 9 페이지

← 이전다음 →